The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Idelalisib (CAL-101) Market Research Report 2025
Synopsis
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
The global Idelalisib (CAL-101) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Idelalisib (CAL-101) include TCI, Biosynth Carbosynth, BOC Sciences, Focus Biomolecules, Adooq Bioscience, Selleck Chemicals, Enzo Biochem, Axon Medchem and BioVision, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Idelalisib (CAL-101), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idelalisib (CAL-101).
Report Scope
The Idelalisib (CAL-101) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Idelalisib (CAL-101) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idelalisib (CAL-101) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idelalisib (CAL-101) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Idelalisib (CAL-101) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Idelalisib (CAL-101) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
The global Idelalisib (CAL-101) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Idelalisib (CAL-101) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Idelalisib (CAL-101) include TCI, Biosynth Carbosynth, BOC Sciences, Focus Biomolecules, Adooq Bioscience, Selleck Chemicals, Enzo Biochem, Axon Medchem and BioVision, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Idelalisib (CAL-101), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idelalisib (CAL-101).
Report Scope
The Idelalisib (CAL-101) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Idelalisib (CAL-101) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idelalisib (CAL-101) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idelalisib (CAL-101) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Idelalisib (CAL-101) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Idelalisib (CAL-101) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Idelalisib (CAL-101) Market Overview
1.1 Product Definition
1.2 Idelalisib (CAL-101) Segment by Type
1.2.1 Global Idelalisib (CAL-101) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Idelalisib (CAL-101) Segment by Application
1.3.1 Global Idelalisib (CAL-101) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Idelalisib (CAL-101) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Idelalisib (CAL-101) Production Estimates and Forecasts (2019-2030)
1.4.4 Global Idelalisib (CAL-101) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Idelalisib (CAL-101) Production Market Share by Manufacturers (2019-2024)
2.2 Global Idelalisib (CAL-101) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Idelalisib (CAL-101), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Idelalisib (CAL-101) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Idelalisib (CAL-101) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Idelalisib (CAL-101), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Idelalisib (CAL-101), Product Offered and Application
2.8 Global Key Manufacturers of Idelalisib (CAL-101), Date of Enter into This Industry
2.9 Idelalisib (CAL-101) Market Competitive Situation and Trends
2.9.1 Idelalisib (CAL-101) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Idelalisib (CAL-101) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Idelalisib (CAL-101) Production by Region
3.1 Global Idelalisib (CAL-101) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Idelalisib (CAL-101) Production Value by Region (2019-2030)
3.2.1 Global Idelalisib (CAL-101) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Idelalisib (CAL-101) by Region (2025-2030)
3.3 Global Idelalisib (CAL-101) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Idelalisib (CAL-101) Production by Region (2019-2030)
3.4.1 Global Idelalisib (CAL-101) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Idelalisib (CAL-101) by Region (2025-2030)
3.5 Global Idelalisib (CAL-101) Market Price Analysis by Region (2019-2024)
3.6 Global Idelalisib (CAL-101) Production and Value, Year-over-Year Growth
3.6.1 North America Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
3.6.5 India Idelalisib (CAL-101) Production Value Estimates and Forecasts (2019-2030)
4 Idelalisib (CAL-101) Consumption by Region
4.1 Global Idelalisib (CAL-101) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Idelalisib (CAL-101) Consumption by Region (2019-2030)
4.2.1 Global Idelalisib (CAL-101) Consumption by Region (2019-2024)
4.2.2 Global Idelalisib (CAL-101) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Idelalisib (CAL-101) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Idelalisib (CAL-101) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Idelalisib (CAL-101) Production by Type (2019-2030)
5.1.1 Global Idelalisib (CAL-101) Production by Type (2019-2024)
5.1.2 Global Idelalisib (CAL-101) Production by Type (2025-2030)
5.1.3 Global Idelalisib (CAL-101) Production Market Share by Type (2019-2030)
5.2 Global Idelalisib (CAL-101) Production Value by Type (2019-2030)
5.2.1 Global Idelalisib (CAL-101) Production Value by Type (2019-2024)
5.2.2 Global Idelalisib (CAL-101) Production Value by Type (2025-2030)
5.2.3 Global Idelalisib (CAL-101) Production Value Market Share by Type (2019-2030)
5.3 Global Idelalisib (CAL-101) Price by Type (2019-2030)
6 Segment by Application
6.1 Global Idelalisib (CAL-101) Production by Application (2019-2030)
6.1.1 Global Idelalisib (CAL-101) Production by Application (2019-2024)
6.1.2 Global Idelalisib (CAL-101) Production by Application (2025-2030)
6.1.3 Global Idelalisib (CAL-101) Production Market Share by Application (2019-2030)
6.2 Global Idelalisib (CAL-101) Production Value by Application (2019-2030)
6.2.1 Global Idelalisib (CAL-101) Production Value by Application (2019-2024)
6.2.2 Global Idelalisib (CAL-101) Production Value by Application (2025-2030)
6.2.3 Global Idelalisib (CAL-101) Production Value Market Share by Application (2019-2030)
6.3 Global Idelalisib (CAL-101) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 TCI
7.1.1 TCI Idelalisib (CAL-101) Corporation Information
7.1.2 TCI Idelalisib (CAL-101) Product Portfolio
7.1.3 TCI Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 TCI Main Business and Markets Served
7.1.5 TCI Recent Developments/Updates
7.2 Biosynth Carbosynth
7.2.1 Biosynth Carbosynth Idelalisib (CAL-101) Corporation Information
7.2.2 Biosynth Carbosynth Idelalisib (CAL-101) Product Portfolio
7.2.3 Biosynth Carbosynth Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Biosynth Carbosynth Main Business and Markets Served
7.2.5 Biosynth Carbosynth Recent Developments/Updates
7.3 BOC Sciences
7.3.1 BOC Sciences Idelalisib (CAL-101) Corporation Information
7.3.2 BOC Sciences Idelalisib (CAL-101) Product Portfolio
7.3.3 BOC Sciences Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 BOC Sciences Main Business and Markets Served
7.3.5 BOC Sciences Recent Developments/Updates
7.4 Focus Biomolecules
7.4.1 Focus Biomolecules Idelalisib (CAL-101) Corporation Information
7.4.2 Focus Biomolecules Idelalisib (CAL-101) Product Portfolio
7.4.3 Focus Biomolecules Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Focus Biomolecules Main Business and Markets Served
7.4.5 Focus Biomolecules Recent Developments/Updates
7.5 Adooq Bioscience
7.5.1 Adooq Bioscience Idelalisib (CAL-101) Corporation Information
7.5.2 Adooq Bioscience Idelalisib (CAL-101) Product Portfolio
7.5.3 Adooq Bioscience Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Adooq Bioscience Main Business and Markets Served
7.5.5 Adooq Bioscience Recent Developments/Updates
7.6 Selleck Chemicals
7.6.1 Selleck Chemicals Idelalisib (CAL-101) Corporation Information
7.6.2 Selleck Chemicals Idelalisib (CAL-101) Product Portfolio
7.6.3 Selleck Chemicals Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Selleck Chemicals Main Business and Markets Served
7.6.5 Selleck Chemicals Recent Developments/Updates
7.7 Enzo Biochem
7.7.1 Enzo Biochem Idelalisib (CAL-101) Corporation Information
7.7.2 Enzo Biochem Idelalisib (CAL-101) Product Portfolio
7.7.3 Enzo Biochem Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Enzo Biochem Main Business and Markets Served
7.7.5 Enzo Biochem Recent Developments/Updates
7.8 Axon Medchem
7.8.1 Axon Medchem Idelalisib (CAL-101) Corporation Information
7.8.2 Axon Medchem Idelalisib (CAL-101) Product Portfolio
7.8.3 Axon Medchem Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Axon Medchem Main Business and Markets Served
7.7.5 Axon Medchem Recent Developments/Updates
7.9 BioVision
7.9.1 BioVision Idelalisib (CAL-101) Corporation Information
7.9.2 BioVision Idelalisib (CAL-101) Product Portfolio
7.9.3 BioVision Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.9.4 BioVision Main Business and Markets Served
7.9.5 BioVision Recent Developments/Updates
7.10 Santa Cruz Biotechnology
7.10.1 Santa Cruz Biotechnology Idelalisib (CAL-101) Corporation Information
7.10.2 Santa Cruz Biotechnology Idelalisib (CAL-101) Product Portfolio
7.10.3 Santa Cruz Biotechnology Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Santa Cruz Biotechnology Main Business and Markets Served
7.10.5 Santa Cruz Biotechnology Recent Developments/Updates
7.11 Clearsynth
7.11.1 Clearsynth Idelalisib (CAL-101) Corporation Information
7.11.2 Clearsynth Idelalisib (CAL-101) Product Portfolio
7.11.3 Clearsynth Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Clearsynth Main Business and Markets Served
7.11.5 Clearsynth Recent Developments/Updates
7.12 LGC
7.12.1 LGC Idelalisib (CAL-101) Corporation Information
7.12.2 LGC Idelalisib (CAL-101) Product Portfolio
7.12.3 LGC Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.12.4 LGC Main Business and Markets Served
7.12.5 LGC Recent Developments/Updates
7.13 LKT Laboratories
7.13.1 LKT Laboratories Idelalisib (CAL-101) Corporation Information
7.13.2 LKT Laboratories Idelalisib (CAL-101) Product Portfolio
7.13.3 LKT Laboratories Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.13.4 LKT Laboratories Main Business and Markets Served
7.13.5 LKT Laboratories Recent Developments/Updates
7.14 Shimadzu
7.14.1 Shimadzu Idelalisib (CAL-101) Corporation Information
7.14.2 Shimadzu Idelalisib (CAL-101) Product Portfolio
7.14.3 Shimadzu Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Shimadzu Main Business and Markets Served
7.14.5 Shimadzu Recent Developments/Updates
7.15 Aladdin
7.15.1 Aladdin Idelalisib (CAL-101) Corporation Information
7.15.2 Aladdin Idelalisib (CAL-101) Product Portfolio
7.15.3 Aladdin Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Aladdin Main Business and Markets Served
7.15.5 Aladdin Recent Developments/Updates
7.16 Cayman Chemical
7.16.1 Cayman Chemical Idelalisib (CAL-101) Corporation Information
7.16.2 Cayman Chemical Idelalisib (CAL-101) Product Portfolio
7.16.3 Cayman Chemical Idelalisib (CAL-101) Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Cayman Chemical Main Business and Markets Served
7.16.5 Cayman Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Idelalisib (CAL-101) Industry Chain Analysis
8.2 Idelalisib (CAL-101) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Idelalisib (CAL-101) Production Mode & Process
8.4 Idelalisib (CAL-101) Sales and Marketing
8.4.1 Idelalisib (CAL-101) Sales Channels
8.4.2 Idelalisib (CAL-101) Distributors
8.5 Idelalisib (CAL-101) Customers
9 Idelalisib (CAL-101) Market Dynamics
9.1 Idelalisib (CAL-101) Industry Trends
9.2 Idelalisib (CAL-101) Market Drivers
9.3 Idelalisib (CAL-101) Market Challenges
9.4 Idelalisib (CAL-101) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Idelalisib (CAL-101) Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Idelalisib (CAL-101) Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Idelalisib (CAL-101) Production Capacity (Kg) by Manufacturers in 2023
Table 4. Global Idelalisib (CAL-101) Production by Manufacturers (2019-2024) & (Kg)
Table 5. Global Idelalisib (CAL-101) Production Market Share by Manufacturers (2019-2024)
Table 6. Global Idelalisib (CAL-101) Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Idelalisib (CAL-101) Production Value Share by Manufacturers (2019-2024)
Table 8. Global Idelalisib (CAL-101) Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Idelalisib (CAL-101) as of 2023)
Table 10. Global Market Idelalisib (CAL-101) Average Price by Manufacturers (K USD/Kg) & (2019-2024)
Table 11. Manufacturers Idelalisib (CAL-101) Production Sites and Area Served
Table 12. Manufacturers Idelalisib (CAL-101) Product Types
Table 13. Global Idelalisib (CAL-101) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Idelalisib (CAL-101) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Idelalisib (CAL-101) Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Idelalisib (CAL-101) Production Value Market Share by Region (2019-2024)
Table 18. Global Idelalisib (CAL-101) Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Idelalisib (CAL-101) Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Idelalisib (CAL-101) Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Table 21. Global Idelalisib (CAL-101) Production (Kg) by Region (2019-2024)
Table 22. Global Idelalisib (CAL-101) Production Market Share by Region (2019-2024)
Table 23. Global Idelalisib (CAL-101) Production (Kg) Forecast by Region (2025-2030)
Table 24. Global Idelalisib (CAL-101) Production Market Share Forecast by Region (2025-2030)
Table 25. Global Idelalisib (CAL-101) Market Average Price (K USD/Kg) by Region (2019-2024)
Table 26. Global Idelalisib (CAL-101) Market Average Price (K USD/Kg) by Region (2025-2030)
Table 27. Global Idelalisib (CAL-101) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 28. Global Idelalisib (CAL-101) Consumption by Region (2019-2024) & (Kg)
Table 29. Global Idelalisib (CAL-101) Consumption Market Share by Region (2019-2024)
Table 30. Global Idelalisib (CAL-101) Forecasted Consumption by Region (2025-2030) & (Kg)
Table 31. Global Idelalisib (CAL-101) Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 33. North America Idelalisib (CAL-101) Consumption by Country (2019-2024) & (Kg)
Table 34. North America Idelalisib (CAL-101) Consumption by Country (2025-2030) & (Kg)
Table 35. Europe Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 36. Europe Idelalisib (CAL-101) Consumption by Country (2019-2024) & (Kg)
Table 37. Europe Idelalisib (CAL-101) Consumption by Country (2025-2030) & (Kg)
Table 38. Asia Pacific Idelalisib (CAL-101) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 39. Asia Pacific Idelalisib (CAL-101) Consumption by Region (2019-2024) & (Kg)
Table 40. Asia Pacific Idelalisib (CAL-101) Consumption by Region (2025-2030) & (Kg)
Table 41. Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 42. Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption by Country (2019-2024) & (Kg)
Table 43. Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption by Country (2025-2030) & (Kg)
Table 44. Global Idelalisib (CAL-101) Production (Kg) by Type (2019-2024)
Table 45. Global Idelalisib (CAL-101) Production (Kg) by Type (2025-2030)
Table 46. Global Idelalisib (CAL-101) Production Market Share by Type (2019-2024)
Table 47. Global Idelalisib (CAL-101) Production Market Share by Type (2025-2030)
Table 48. Global Idelalisib (CAL-101) Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Idelalisib (CAL-101) Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Idelalisib (CAL-101) Production Value Share by Type (2019-2024)
Table 51. Global Idelalisib (CAL-101) Production Value Share by Type (2025-2030)
Table 52. Global Idelalisib (CAL-101) Price (K USD/Kg) by Type (2019-2024)
Table 53. Global Idelalisib (CAL-101) Price (K USD/Kg) by Type (2025-2030)
Table 54. Global Idelalisib (CAL-101) Production (Kg) by Application (2019-2024)
Table 55. Global Idelalisib (CAL-101) Production (Kg) by Application (2025-2030)
Table 56. Global Idelalisib (CAL-101) Production Market Share by Application (2019-2024)
Table 57. Global Idelalisib (CAL-101) Production Market Share by Application (2025-2030)
Table 58. Global Idelalisib (CAL-101) Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Idelalisib (CAL-101) Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Idelalisib (CAL-101) Production Value Share by Application (2019-2024)
Table 61. Global Idelalisib (CAL-101) Production Value Share by Application (2025-2030)
Table 62. Global Idelalisib (CAL-101) Price (K USD/Kg) by Application (2019-2024)
Table 63. Global Idelalisib (CAL-101) Price (K USD/Kg) by Application (2025-2030)
Table 64. TCI Idelalisib (CAL-101) Corporation Information
Table 65. TCI Specification and Application
Table 66. TCI Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 67. TCI Main Business and Markets Served
Table 68. TCI Recent Developments/Updates
Table 69. Biosynth Carbosynth Idelalisib (CAL-101) Corporation Information
Table 70. Biosynth Carbosynth Specification and Application
Table 71. Biosynth Carbosynth Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 72. Biosynth Carbosynth Main Business and Markets Served
Table 73. Biosynth Carbosynth Recent Developments/Updates
Table 74. BOC Sciences Idelalisib (CAL-101) Corporation Information
Table 75. BOC Sciences Specification and Application
Table 76. BOC Sciences Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 77. BOC Sciences Main Business and Markets Served
Table 78. BOC Sciences Recent Developments/Updates
Table 79. Focus Biomolecules Idelalisib (CAL-101) Corporation Information
Table 80. Focus Biomolecules Specification and Application
Table 81. Focus Biomolecules Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 82. Focus Biomolecules Main Business and Markets Served
Table 83. Focus Biomolecules Recent Developments/Updates
Table 84. Adooq Bioscience Idelalisib (CAL-101) Corporation Information
Table 85. Adooq Bioscience Specification and Application
Table 86. Adooq Bioscience Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 87. Adooq Bioscience Main Business and Markets Served
Table 88. Adooq Bioscience Recent Developments/Updates
Table 89. Selleck Chemicals Idelalisib (CAL-101) Corporation Information
Table 90. Selleck Chemicals Specification and Application
Table 91. Selleck Chemicals Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 92. Selleck Chemicals Main Business and Markets Served
Table 93. Selleck Chemicals Recent Developments/Updates
Table 94. Enzo Biochem Idelalisib (CAL-101) Corporation Information
Table 95. Enzo Biochem Specification and Application
Table 96. Enzo Biochem Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 97. Enzo Biochem Main Business and Markets Served
Table 98. Enzo Biochem Recent Developments/Updates
Table 99. Axon Medchem Idelalisib (CAL-101) Corporation Information
Table 100. Axon Medchem Specification and Application
Table 101. Axon Medchem Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 102. Axon Medchem Main Business and Markets Served
Table 103. Axon Medchem Recent Developments/Updates
Table 104. BioVision Idelalisib (CAL-101) Corporation Information
Table 105. BioVision Specification and Application
Table 106. BioVision Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 107. BioVision Main Business and Markets Served
Table 108. BioVision Recent Developments/Updates
Table 109. Santa Cruz Biotechnology Idelalisib (CAL-101) Corporation Information
Table 110. Santa Cruz Biotechnology Specification and Application
Table 111. Santa Cruz Biotechnology Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 112. Santa Cruz Biotechnology Main Business and Markets Served
Table 113. Santa Cruz Biotechnology Recent Developments/Updates
Table 114. Clearsynth Idelalisib (CAL-101) Corporation Information
Table 115. Clearsynth Specification and Application
Table 116. Clearsynth Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 117. Clearsynth Main Business and Markets Served
Table 118. Clearsynth Recent Developments/Updates
Table 119. LGC Idelalisib (CAL-101) Corporation Information
Table 120. LGC Specification and Application
Table 121. LGC Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 122. LGC Main Business and Markets Served
Table 123. LGC Recent Developments/Updates
Table 124. LKT Laboratories Idelalisib (CAL-101) Corporation Information
Table 125. LKT Laboratories Specification and Application
Table 126. LKT Laboratories Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 127. LKT Laboratories Main Business and Markets Served
Table 128. LKT Laboratories Recent Developments/Updates
Table 129. Shimadzu Idelalisib (CAL-101) Corporation Information
Table 130. Shimadzu Specification and Application
Table 131. Shimadzu Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 132. Shimadzu Main Business and Markets Served
Table 133. Shimadzu Recent Developments/Updates
Table 134. Shimadzu Idelalisib (CAL-101) Corporation Information
Table 135. Aladdin Specification and Application
Table 136. Aladdin Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 137. Aladdin Main Business and Markets Served
Table 138. Aladdin Recent Developments/Updates
Table 139. Cayman Chemical Idelalisib (CAL-101) Corporation Information
Table 140. Cayman Chemical Idelalisib (CAL-101) Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 141. Cayman Chemical Main Business and Markets Served
Table 142. Cayman Chemical Recent Developments/Updates
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Idelalisib (CAL-101) Distributors List
Table 146. Idelalisib (CAL-101) Customers List
Table 147. Idelalisib (CAL-101) Market Trends
Table 148. Idelalisib (CAL-101) Market Drivers
Table 149. Idelalisib (CAL-101) Market Challenges
Table 150. Idelalisib (CAL-101) Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Idelalisib (CAL-101)
Figure 2. Global Idelalisib (CAL-101) Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Idelalisib (CAL-101) Market Share by Type: 2023 VS 2030
Figure 4. Min Purity Less Than 98% Product Picture
Figure 5. Min Purity 98%-99% Product Picture
Figure 6. Min Purity More Than 99% Product Picture
Figure 7. Global Idelalisib (CAL-101) Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 8. Global Idelalisib (CAL-101) Market Share by Application: 2023 VS 2030
Figure 9. Research
Figure 10. Medical
Figure 11. Global Idelalisib (CAL-101) Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Idelalisib (CAL-101) Production Value (US$ Million) & (2019-2030)
Figure 13. Global Idelalisib (CAL-101) Production Capacity (Kg) & (2019-2030)
Figure 14. Global Idelalisib (CAL-101) Production (Kg) & (2019-2030)
Figure 15. Global Idelalisib (CAL-101) Average Price (K USD/Kg) & (2019-2030)
Figure 16. Idelalisib (CAL-101) Report Years Considered
Figure 17. Idelalisib (CAL-101) Production Share by Manufacturers in 2023
Figure 18. Idelalisib (CAL-101) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Idelalisib (CAL-101) Revenue in 2023
Figure 20. Global Idelalisib (CAL-101) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Idelalisib (CAL-101) Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Idelalisib (CAL-101) Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 23. Global Idelalisib (CAL-101) Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Idelalisib (CAL-101) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Idelalisib (CAL-101) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Idelalisib (CAL-101) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Idelalisib (CAL-101) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. India Idelalisib (CAL-101) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Idelalisib (CAL-101) Consumption by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 30. Global Idelalisib (CAL-101) Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 32. North America Idelalisib (CAL-101) Consumption Market Share by Country (2019-2030)
Figure 33. Canada Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 34. U.S. Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 35. Europe Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 36. Europe Idelalisib (CAL-101) Consumption Market Share by Country (2019-2030)
Figure 37. Germany Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 38. France Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 39. U.K. Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 40. Italy Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 41. Russia Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 42. Asia Pacific Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 43. Asia Pacific Idelalisib (CAL-101) Consumption Market Share by Regions (2019-2030)
Figure 44. China Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 45. Japan Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 46. South Korea Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 47. China Taiwan Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 48. Southeast Asia Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 49. India Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 50. Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 51. Latin America, Middle East & Africa Idelalisib (CAL-101) Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 53. Brazil Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 54. Turkey Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 55. GCC Countries Idelalisib (CAL-101) Consumption and Growth Rate (2019-2024) & (Kg)
Figure 56. Global Production Market Share of Idelalisib (CAL-101) by Type (2019-2030)
Figure 57. Global Production Value Market Share of Idelalisib (CAL-101) by Type (2019-2030)
Figure 58. Global Idelalisib (CAL-101) Price (K USD/Kg) by Type (2019-2030)
Figure 59. Global Production Market Share of Idelalisib (CAL-101) by Application (2019-2030)
Figure 60. Global Production Value Market Share of Idelalisib (CAL-101) by Application (2019-2030)
Figure 61. Global Idelalisib (CAL-101) Price (K USD/Kg) by Application (2019-2030)
Figure 62. Idelalisib (CAL-101) Value Chain
Figure 63. Idelalisib (CAL-101) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
